| AFDAX | VTSAX | AFDAX / VTSAX | |
| Total Expense Ratio | 1.04 | 0.04 | 2,600% |
| Annual Report Gross Expense Ratio | 1.04 | 0.04 | 2,600% |
| Fund Existence | 21 years | 25 years | - |
| Gain YTD | 9.753 | 13.952 | 70% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.4B | 2.05T | 0% |
| Annual Yield % from dividends | 0.26 | 1.11 | 24% |
| Returns for 1 year | 1.42 | 11.52 | 12% |
| Returns for 3 years | 47.13 | 66.89 | 70% |
| Returns for 5 years | 59.67 | 80.80 | 74% |
| Returns for 10 years | 179.68 | 225.71 | 80% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IVHIX | 5.94 | N/A | N/A |
| Macquarie High Income Fund Class I | |||
| WLTTX | 13.00 | -0.12 | -0.91% |
| Wilshire International Equity Instl | |||
| JVACX | 39.28 | -0.36 | -0.91% |
| JPMorgan Value Advantage C | |||
| AMTYX | 10.69 | -0.11 | -1.02% |
| AB All Market Real Return Advisor | |||
| LYFAX | 15.17 | -0.19 | -1.24% |
| AlphaCentric Life Sciences & Hlthcare A | |||